The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously ...

Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...

Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing ...

"She lived 11 of her 14 years with a relentless cancer, yet lived more fully and gratefully than most," her family said of ...

Teen influencer Zuza Beine died at the age of 14 from leukemia on Tuesday after sharing her life and treatments online for ...

Once I was able to move out of my brother and sister-in-law’s home, I found a pleasurable and adequately challenging job. One ...

Approximately 60% to 70% of patients aged 18 to 65 years will achieve a complete remission, but just 30.5% of these patients ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical ...

The event will feature an overview of the ongoing Phase 3 REGAL trial of GPS (results expected by year-end) and a discussion of the unmet needs of AML patients in complete second remission (CR2).

Former journalist Loriana Hernández-Aldama speaks on journey through breast cancer, leukemia. She is sending an important ...

Thanks to efforts from doctors, researchers, health care providers and nonprofits such as Blood Cancer United, certain types of blood cancers are not the terminal diagnoses that these were decades ago ...